Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus

Hypertension subtypes modify metabolic response to thiazide diuretics

(2015) Chin-Chou Huang et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet

(2013) Tsutomu Wada et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

More than a simple storage organ: Adipose tissue as a source of adipokines involved in cardiovascular disease

(2013) Gersina Rega-Kaun et al.   THROMBOSIS AND HAEMOSTASIS

Mineralocorticoid receptor antagonists: their use and differentiation in Japan

(2012) Atsuhisa Sato   HYPERTENSION RESEARCH

Comparison of medium-dose losartan/hydrochlorothiazide and maximal-dose angiotensin II receptor blockers in the treatment of Japanese patients with uncontrolled hypertension: the Kobe-CONNECT Study

(2012) Ryuji Toh et al.   HYPERTENSION RESEARCH

Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension

(2012) Pieter M. Jansen et al.   JOURNAL OF HYPERTENSION

Effects of a low-dose antihypertensive diuretic in combination with losartan, telmisartan, or candesartan on serum urate levels in hypertensive patients

(2011) Toshihiro Hamada et al.   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH

Combination of Angiotensin II Receptor Antagonist with Calcium Channel Blocker or Diuretic as Antihypertensive Therapy for Patients with Chronic Kidney Disease

(2011) Toshihiko Ishimitsu et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

The Relationship Between Osteopontin and Adiponectin in Patients with Essential Hypertension

(2010) Mie Kurata et al.   CLINICAL AND EXPERIMENTAL HYPERTENSION

Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet

(2010) Tsutomu Wada et al.   ENDOCRINOLOGY

Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice

(2009) Ayumu Hirata et al.   CARDIOVASCULAR RESEARCH

Clinical effects of eplerenone, a selective aldosterone blocker, in Japanese patients with essential hypertension

(2009) A Sato et al.   JOURNAL OF HUMAN HYPERTENSION

Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline

(2008) John W. Funder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM